Physician profile
John C Saunders
NPI 1609004761
$286.07
in general payments reported to CMS, 2019-2025
10 companies · $59.07 in 2025
The $59.07 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.30 · 2020: $49.41 · 2021: $11.78 · 2022: $17.15 · 2023: $15.48 · 2024: $47.88 · 2025: $59.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $85.30 | 2019 | |
| Depuy Synthes Sales INC. | $49.41 | 2020 | |
| Smith+Nephew, INC. | $31.15 | 2024 | Stravix |
| Innovation Technologies INC | $27.82 | 2025 | Irrisept |
| Boston Scientific Corporation | $17.15 | 2022 | |
| Convatec INC. | $17.01 | 2025 | |
| Abbvie INC. | $16.73 | 2024 | |
| Abbott Laboratories | $15.48 | 2023 | Proclaim |
| Bioventus LLC | $14.24 | 2025 | Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.